Obviously that's true, but given the efficacy for

Obviously that's true, but given the efficacy for both COVID and HIV and the stellar safety profile, I would find it hard to believe that CYDY will have a hard time finding doctors and/or patients who will want to use leronlimab, PLUS there is every reason to believe that some kind of partnership or something with big pharma would be in the works if the COVID results are what we have been led to believe they will be. Here's hoping NP wasn't just being a "man of faith" as so many like to say here when defending his every move.